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BY-NC-ND license (http://creativecomBackground/Purpose: To analyze the polymorphism of the IL-22 gene in Han Chinese patients
and to evaluate the influence of IL-22 polymorphism on human immunodeficiency virus (HIV)
infection.
Methods: IL-22 gene polymorphism was analyzed in 73 blood samples from healthy partici-
pants. The influence of the genotype and allele distribution of three single nucleotide poly-
morphisms (rs2227484, rs2227485, and rs2227513) of IL-22 on HIV infection was evaluated in
619 HIV seropositive patients and 619 healthy controls. To determine the association between
the rs2227513 genotype and IL-22 levels in plasma, we randomly selected 29 HIV seropositive
blood samples and 15 healthy blood samples and measured the levels of IL-22.
Results: Nine single nucleotide polymorphism loci of the IL-22 gene were found (rs2227484,
rs2227485, rs2227491, rs2227508, rs2227513, rs1179249, rs1179250, rs1179251, and
rs1182844). Stratified analysis (by sex) showed a higher association of HIV infection and the
A/G genotype and G allele at rs2227513 in women, but not in men (A/G genotype odds
ratioZ 5.24, 95% confidence intervalZ 1.13e24.27; allele G odds ratioZ 5.27, 95% confidence
interval 1.15e24.23). The rs2227513 A/G genotype was also associated with significantly higher
levels of plasma IL-22, regardless of whether the patient was HIV seropositive or seronegative.t of Neurology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University. Number 107 West Yanjiang
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China is a huge country with one-quarter of the world’s
population. The majority of the population (91.51%) is Han
Chinese. China has been experiencing one of the most
rapidly growing epidemics of human immunodeficiency
virus (HIV) infection in the world over the past 20 years. By
the end of 2011, >780,000 adults and children were esti-
mated to be living with HIV infection, with an estimated
overall HIV prevalence of 0.058% of the total population.
High infection rates of HIV are concentrated among specific
sub-populations, such as intravenous drug users, sex
workers, and men who have sex with men.1 Although there
is still no effective vaccine and no cure for HIV infection
and AIDS, viral susceptibility shows individual heterogene-
ity, which has suggested potential targets for treatment.2
Patients who have maintained resistance to HIV infection
after high-risk exposure have been documented in
numerous cohorts from across the globe, including com-
mercial sex workers and those practicing unprotected
heterosexual or homosexual sexual intercourse with an HIV-
infected partner.3e5 The underlying mechanisms of indi-
vidual heterogeneity are not fully explained, but many
published studies have revealed a key role of genetic
variation in the host.6e8 From the early 1980s, genetic
variants have been identified by using a combination of
candidate gene analysis and unbiased genome-wide asso-
ciation scans; the results explain, in part, the observed
variation in HIV susceptibility.
Interleukin-22 was first described in 2000 by Dumoutier
et al.9 It is a member of the IL-10 family and is produced by
special immune cell populations, including specific T and NK
cells, and lymphoid tissue inducer cells. The target cells of
IL-22 are certain tissue cells from the skin, liver, and kid-
ney, and from organs of the respiratory and gastrointestinal
systems. Increased IL-22 expression has been observed in
human infectious diseases, such as Mycobacterium tuber-
culosis infection and abdominal sepsis.10e12 Moreover, IL-22
plays a part in host resistance to HIV infection.13 Misse´
et al14 carried out complementary transcriptome and pro-
teome analyzes on blood samples from repeatedly HIV-
exposed, uninfected patients and found increased blood
IL-22 levels and increased IL-22 production in vitro via anti-
CD3/anti-CD28-activated T cells. Several studies have
explored the role of IL-22 in HIV infection and defense, with
mixed results.15e17 In this study, we analyzed the sequence
polymorphism of the IL-22 gene in Han Chinese participants
and evaluated the influence of the genotype and allele
distribution of three single nucleotide polymorphisms
(SNPs) of IL-22 on HIV infection in 619 HIV seropositive Han
Chinese patients and 619 healthy Han Chinese controls. We
also investigated the levels of IL-22 and its association with
gene polymorphisms and HIV infection.Materials and methods
Research protocols were approved by the institutional
ethics review board of Sun Yat-Sen Memorial Hospital.
Informed consent was obtained from all the participants
before the samples were collected, in accordance with the
Declaration of Helsinki.
Sequence polymorphism of IL-22 gene
Sample collection
A total of 73 samples of peripheral venous blood fromhealthy
participants attending for voluntary counseling and testing in
Shenzhen Center for Disease Control and Prevention,
Shenzhen, China were included in this study. All of the study
participants (aged 39.2 10.7 years, 37 men and 36 women)
were from aHan Chinese population living in south China and
had no direct relationships. Patients with HIV, hepatitis B
virus (HBV), hepatitis C virus (HCV), Treponema pallidum
infection, inflammation, tumor, family history, or other
serious diseases were intentionally excluded.
DNA sequencing
The genomic DNA of peripheral blood mononuclear cells of
each participant was extracted from 200 mL of EDTA-
anticoagulated peripheral blood samples with the QIAamp
DNA Blood Mini Kit (Qiagen GmbH, Duesseldorf, Germany)
according to the manufacturer’s protocol.
DNA sequencing was performed using a SangonBiotech
(Shanghai) Co. Ltd ABI 3730xl DNA Analyzer (ABI Inc., Foster
City, CA, USA). The sequencing reaction system included
the purified polymerase chain reaction (PCR) production,
primers for sequencing, Taq polymerase, and ABI PRISM
BigDye terminators. The sequencing curve was analyzed by
Chromas software version 2.33 (http://www.Technelysium.
Com.au/chromas.html).
Two software packages, BioEdit version 7.0.9 (http://
www.mbio.ncsu.edu/BioEdit/bioedit.html) and CLUSTALX
version 1.8 (flp://fip-igbmc.u.strasbg.fi-/pub/ClustalX/)
were used to compile the sequence, matching the sequence
multiple and confirming the potential SNP loci. The geno-
type of the SNPs was checked at least three times.
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Participants
Six hundred and nineteen HIV-1 seropositive peripheral
blood samples were collected in Shenzhen Center for Dis-
ease Control and Prevention from January 2005 to
December 2009. The inclusion criteria for the HIV group
were: (1) Han Chinese ethnicity; (2) the exclusion of
Treponema pallidum infection; and (3) the exclusion of a
874 J. Hu et al.history of tumor. Six hundred and nineteen healthy Han
Chinese participants were matched for age and sex. Table 1
shows the demographic parameters of the HIV-1 seroposi-
tive patients and controls.
Plasma IL-22
Plasma levels of IL-22 were measured by using a Human IL-22
Quantikine ELISA Kit (R&D System, Minneapolis, MN, USA)
according tomanufacturer’s specifications. In brief, thewells
were blockedwith 100 mL/well of assay diluent and incubated
for 2 hours at room temperature. The plate was then incu-
bated for 2 hours at room temperature after the addition of
100 mL/well of supernatants and standards. IL-22 conjugate
(200 mL/well) was added and incubated for 2 hours at room
temperature. Each of these steps was interspersed with four
washes. Thewells were incubatedwith the substrate solution
(200 mL/well) for 30 minutes at room temperature. The stop
solution (50 mL/well) was added and absorbance was
measured at 450 nm and subtracted by the absorbance values
at 540 nm. Samples were assayed in duplicate.
Statistical analysis
The HardyeWeinberg equilibrium test was performed by
Haploview software version 4.2 (Broad Institute, Cambridge,
MA, USA). The HardyeWeinberg equilibrium linkage disequi-
librium was analyzed using Haploview software (version 4.2);
the haplotype reconstruction was analyzed by a Software
Package for Phylogenetics And Sequence Evolution (PHASE)
software (version 2.1) based on a Bayesian statistical
approach. The genotype frequencies were compared by the
Chi-square test or Fisher’s exact test. The 95% confidence
interval for the odds ratio parameter was calculated. The
independent sample t test, one-way analysis of variance, and
Lenene’s test were used for the equal variances. Testing was
performed at the 0.05 level of significance.
Results
Genotype distribution and allele frequency of IL-22
SNPs
The IL-22 gene sequence included five introns and six
exons. The sequenced region of the IL-22 gene included theTable 1 Demographic characteristics of HIV-1 seroposi-
tive patients and healthy controls
Parameter HIV-1 seropositive
patients (n Z 619)
Healthy controls
(n Z 619)
Median (range) age 30 (17e73) 29 (17e68)
Male sex 442 442
Female sex 177 177
Heterosexual
transmissiona
318 (162:156) d
Homosexual
transmissiona
130 (130:0) d
Intravenous
drug abusea
147 (134:13) d
Blood transmissiona 24 (16:8) d
a Data presented as n (male:female).majority of the exons, part of the introns, a 50 untranslated
region, and a 30 untranslated region (Fig. 1). Nine SNP loci
were found and there was no polymorphism in the coding
region. rs2227484 and rs2227485 were located in promoter
region; rs2227513 was located in the first intron area;
rs2227491 was located in the third intron area; rs1179251,
rs1179250, and rs1179249 were located in the fifth intron
area; and rs2227508 and rs1182844 were located in the 30
untranslated region. Haploview (version 4.2) was used to
analyze the frequency of SNP alleles. The consistency of all
the genotype frequencies was accorded with Har-
dyeWeinberg equilibrium.Figure 1. (A) Schematic diagram of the sequencing region
for the IL-22 gene. (B) Locus disequilibrium sketch map of
standard colors for IL-22 SNPs in Han Chinese participants.
Different colors represent different ranges of D0 and LOD be-
tween two loci. Blue, D0 Z 1, LOD < 2; shiny red, D0 Z 1,
LOD  2; white, D0 < 1, LOD < 2; light red, D0 < 1, LOD  2. (C)
Locus disequilibrium sketch map of r2 color for IL-22 SNPs in
Han Chinese participants. Different colors represent different
ranges of r2. White, r2Z 0; gray, 0 < r2 < 1; and black, r2Z 1.
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analyzed with Haploview software (version 4.2). There was
a haplotype block (Fig. 1), which included seven loci:
rs2227508, rs1179249, rs1179250, rs1179251, rs2227491,
rs2227485, and rs1182844.
Five taggers of the SNPs were screened according to the
principle of r2  0.8 and multi-marker tests limit of
detection 3 from nine SNPs. There was no captured allele
of the SNP locus because there was no strong site associ-
ated with rs2227513 and rs11828445. The mean of r2 of
these five tagger SNPs and the alleles captured SNPs is
0.988.Genotype distribution and allele frequency of IL-22
SNPs (rs2227484, rs2227485, and rs2227513) and
the association with HIV infection
Nine SNPs of IL-22 were identified in the Han Chinese par-
ticipants. Among these, rs2227484, rs2227485, and
rs2227513 were found in the putative promoter region. We
analyzed the genotype and allele distribution of these
three SNPs of IL-22 in 619 HIV seropositive Han Chinese
patients and 619 healthy Han Chinese controls. The allele
frequency and HardyeWeinberg equilibrium test for three
SNPs in groups were comparable with the distributions
analyzed in the 73 healthy participants.
The frequency of the C/T genotype and the T allele at
rs2227484 in HIV seropositive patients infected via hetero-
sexual transmission in men were significantly lower
compared with the controls (C/T genotype frequency 6.8%
vs. 16.1%, p Z 0.003, odds ratio (OR) Z 0.378, 95% confi-
dence interval (CI)Z 0.195e0.733; T allele frequency 3.4%
vs. 8.7%, p Z 0.002, OR Z 0.368, 95% CI Z 0.193e0.702;
see supplementary data). The frequency of the C/T geno-
type and T allele at rs2227484 in HIVþ/HBV/HCV pa-
tients were significantly lower as compared with that in
control (C/T genotype frequency 8.9% vs. 16.1%, pZ 0.042,
ORZ 0.505, 95% CIZ 0.258e0.985; T allele frequency 4.4%
vs. 8.7%, p Z 0.026, OR Z 0.486, 95% CI Z 0.254e0.930;
see supplementary data). These results indicated that the
C/T genotype and T allele at rs2227484 were associated
with a lower risk of HIV infection in these subgroups. In
addition, the frequency of the C/T genotype and the
T allele at rs2227484 in HIV and HBV and/or HCV seroposi-
tive patients in men were significantly lower compared with
controls (C/T genotype frequency 0 vs. 16.1%, p Z 0.003;
T allele frequency 0 vs. 8.7%, pZ 0.003; see supplementary
data), which suggested that the C/T genotype and T allele
at rs2227484 were associated with a lower risk of HIV and
hepatitis virus co-infection in this subgroup.
The distribution of genotypes among patients with HIV
infection and controls were comparable for rs2227485 and
no significant association was observed (see supplementary
data).
The frequencies of the A/G genotype and G allele at
rs2227513 in HIV seropositive patients were significantly
higher than in controls (A/G genotype: frequency 2.9% vs.
1.1%, p Z 0.026, OR Z 2.62, 95% CI Z 1.09e6.32; allele G
frequency 1.5% vs. 0.6%, p Z 0.027, OR Z 2.60, 95%
CI Z 1.08e6.23; supplementary data). Stratified analysis
(by sex) showed an increased risk of HIV infection inrelation to the A/G genotype and the G allele at rs2227513
in women but not in men (A/G genotype frequency 5.6% vs.
1.1%, pZ 0.035, ORZ 5.24, 95% CIZ 1.13e24.27; allele G
frequency 2.8% vs. 0.6%, p Z 0.02, OR Z 5.27, 95%
CI Z 1.15e24.23; see supplementary data).
Haplotype frequency distribution in IL-22 promoter
region and the association with HIV infection
Haplotype analysis was performed for HIV seropositive pa-
tients versus controls and four haplotypes of rs2227484-
rs2227485-rs2227513 were observed. Compared with the C-
T-A haplotype, the C-T-G haplotype was associated with a
higher risk of HIV infection, particularly for women and
heterosexuals (HIV seropositive patients vs. controls fre-
quency 1.5% vs. 0.57%, p Z 0.029, OR Z 2.571, 95%
CI Z 1.066e6.202; HIV seropositive patients vs. controls
(women) frequency 2.9% vs. 0.56%, pZ 0.021, ORZ 5.088,
95% CI Z 1.099e23.566; HIV seropositive patients infected
via heterosexual transmission vs. controls frequency 2.0%
vs. 0.57%, p Z 0.004, OR Z 3.635, 95% CI Z 1.435e9.205;
HIV seropositive patients infected via heterosexual trans-
mission vs. controls (women) frequency 2.6% vs. 0.6%,
p Z 0.04, OR Z 4.494, 95% CI Z 1.040e21.483; see
supplementary data). The T-C-A haplotype was associated
with a decreased risk of HIV infection in heterosexual men
(frequency 3.4% vs. 8.6%, p Z 0.006, OR Z 0.406, 95%
CI Z 0.210e0.786, see supplementary data). In addition,
the frequency of the C-T-G haplotype in HIV seropositive
patients infected via drug abuse transmission was signifi-
cantly higher compared with controls (frequency 7.7% vs.
0.6%, p Z 0.021, ORZ 17.3, 95% CIZ 2.203e135.874; see
supplementary data), indicating a higher risk of HIV infec-
tion in drug abusers with the C-T-G haplotype.
IL-22 plasma levels and rs2227513 polymorphism
To determine the association between the rs2227513 ge-
notype and IL-22 levels in plasma, we randomly selected 29
HIV seropositive blood samples and 15 healthy blood sam-
ples and measured the levels of IL-22. The demographic
parameters are shown in Table 2. Table 3 shows that the
rs2227513 A/G genotype was associated with significantly
higher levels of IL-22 than the A/A genotype, regardless of
whether the patient was HIV seropositive or seronegative.
Discussion
Genetic factors alter the susceptibility to HIV in the human
population and a particular group of people who are
exposed to HIV may remained uninfected: “HIV-resistant”
individuals.6,18 In our study, the sequence polymorphism of
the IL-22 genes was analyzed and nine SNPs loci (rs2227484,
rs2227485, rs2227491, rs2227508, rs2227513, rs1179249,
rs1179250, rs1179251, and rs1182844) were found and
verified in Han Chinese participants. We also evaluated the
genotype and allele distribution of three SNPs of IL-22
(rs2227484, rs2227485, and rs2227513) in 619 HIV seropos-
itive Han Chinese patients and 619 healthy Han Chinese
controls and investigated the IL-22 plasma levels and their
association with gene polymorphisms and HIV infection. We
Table 2 Demographic characteristics of blood samples for IL-22 detection
Parameter HIV-1 seropositive patients (n Z 29) Healthy controls (n Z 15)
rs2227513 genotype A/G (n Z 18) A/A (n Z 11) A/G (n Z 7) A/A (n Z 8)
Mean  SD age* 29.61  4.9 32.81  5.1 29.85  4.3 28.87  4.4
Sex (male:female) 8:10 5:6 5:2 4:4
*p Z 0.287.
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type and G allele at rs2227513, particularly in women. A
further investigation of IL-22 levels in plasma showed that
the A/G genotype at rs2227513 was associated with signif-
icantly higher levels of IL-22 than the A/A genotype,
regardless of whether the patient was HIV seropositive or
seronegative. These results suggest that IL-22 production in
blood might act as a pathogenic factor in HIV infection.
IL-22 is a cytokine produced by immune cells and is
important for the regulation of tissue cell responses during
inflammation and infection. Many studies have described
increased IL-22 production in vivo, including in inflamma-
tion and infection. The cellular sources of IL-22 in these
studies varied depending on the location and nature of the
affected tissue and the time of analysis. Increased IL-22
levels were found in several different chronic inflamma-
tory conditions, including psoriasis, active Crohn’s disease,
and rheumatoid arthritis. IL-22 can have either a protective
or a pathogenic role in chronic inflammatory diseases.19e21
IL-22 also has a possible role in the innate immune defense
against pathogens, e.g., bacteria and viruses. IL-22 regu-
lates antimicrobial protein production and neutrophil
recruitment and thus enhances the basic innate barrier
defenses to enteric bacterial pathogens at mucosal
surfaces.22,23
The role of IL-22 in antiviral defense is still controver-
sial. Misse´ et al14 found upregulated cell supernatant and
plasma levels of IL-22 in repeatedly HIV-exposed, unin-
fected participants. However, Chege et al15 concluded that
HIV exposure without infection was associated with
reduced production of IL-22, both systemically and at the
site of mucosal HIV exposure. In this study, we found that
there was an increased risk of HIV infection related to the
A/G genotype at rs2227513. Further analysis showed an
association between this polymorphism and significantly
higher levels of IL-22, regardless of whether the patient
was HIV seropositive or seronegative. Our results indicate a
pathogenic role of IL-22 production on HIV infection and
revealed the effect of genetic polymorphism in this pro-
cess. With respect to the underlying mechanisms, studies
have shown that IL-22 signaling, through its IL-22R receptor,
plays a critical part in the promotion of antimicrobialTable 3 Comparison of IL-22 levels between A/G and A/A
genotypes at rs2227513
Genotype No. of
samples
IL-22 (pg/mL) ManneWhitney
U test
p
A/G 25 30.63  31.36 d d
A/A 19 11.19  7.43 69 <0.001immunity, inflammation, and normal barrier homeostasis.
These include stimulating the secretion of antimicrobial
proteins and enhancing tissue repair.24 In repeatedly HIV-
exposed, uninfected individuals, increased production of
IL-22 by T cells is reflected in a specific increase in the
secretion levels of the acute phase serum amyloid A (A-
SAA). A-SAA plays a beneficial part in the host innate de-
fense during the acute phase of inflammation and induces
phosphorylation of the cellular HIV coreceptor CCR5 in
myeloid immature dendritic cells. CCR5 phosphorylation
results in a strongly decreased infection rate of immature
dendritic cells during HIV exposure.14 Moreover, some
research has indicated that IL-22 and IL-17 may work in
tandem to protect against HIV. IL-17 was found to be
secreted by a number of RAR-related orphan receptor gt
expression cells, including Th17 cells, CD8þ ab T cells, gd T
cells, lymphoid tissue inducer (LTi) cells, LTi-like innate
lymphoid cells, invariant natural killer T cells, and mucosal-
associated invariant T cells, which also secrete IL-22.22,25
IL-17 augments inflammation in immune defense to extra-
cellular pathogens and IL-22 shows tissue-protective ef-
fects, including reinforcing the tight junctions between
enterocytes and enhancing epithelial cell proliferation. The
IL-17eIL-22 axis was indicated to play a crucial part in
maintaining mucosal immunity and barrier integrity.23 The
role of IL-22 in HIV infection and the underlying mecha-
nisms are therefore not yet well understood. It will be
important for further studies to examine the causal nature
of the association and to define the cell subsets responsible
for these differences.
In our study, the frequency of the C/T genotype and T
allele at rs2227484 in HIV seropositive male patients
infected via heterosexual transmission were significantly
lower than in controls. Stratified analysis (by sex) showed
an increased risk of HIV infection in relation to the A/G
genotype and G allele at rs2227513 in women, but not in
men. These results suggested sex differences in IL-22 SNP
polymorphism in HIV infection. Evidence has shown that
women and men are different in their susceptibility and
response to infectious diseases. The mechanisms respon-
sible for these sex-based differences include immunological
pathways affected by sex hormones, differential expression
of X-chromosome-encoded genes on immune responses to
pathogens, as well as cultural and behavioral differences
between the sexes.26 With regard to sex differences in gene
polymorphism, Schoultz et al27 found combined poly-
morphisms in certain inflammation-related genes in the
development of Crohn’s disease in men, but not in women,
suggesting a role of sex differences in the pattern of ge-
netic susceptibility in the innate immune response.
We found that the rs2227513 A/G genotype was associ-
ated with significantly higher levels of IL-22 than the A/A
Impact of IL-22 gene polymorphism in HIV infection 877genotype, regardless of whether the patient was HIV sero-
positive or seronegative. rs2227513 resides in the first
intron of the IL-22 gene. It has been determined that
intronic SNPs modulate gene expression.28,29 Xu et al30
found certain proteins were the major binding partner for
the G-containing SNP site. The G-to-A transition weakens
protein binding and facilitates exon skipping, leading to
altered gene expression. Intronic SNPs may play a part by
affecting microRNA-to-mRNA binding or through locus
disequilibrium with another SNP.31,32 However, how the
rs2227513 intronic SNP of IL-22 affects transcription and
gene expression remains uncertain.
This study found and verified nine SNP loci of the IL-22
gene in Han Chinese participants and an increased risk of
HIV infection was associated with IL-22 polymorphism.
Further detection of IL-22 levels in plasma showed that the
A/G genotype at rs2227513 was associated with signifi-
cantly higher levels of IL-22 compared with the A/A geno-
type, regardless of whether the patient was HIV
seropositive or seronegative. These results suggest that IL-
22 production in blood might act as a pathogenic factor in
HIV infection.
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